We found that urine NDRG1 could be a promising biomarker for the diagnosis of bladder cancer, with an AUC of 0.909 (95% CI, 0.829–0.989), an acceptable sensitivity of 84.6% and a specificity of 86.7%. The gene discussed is NDRG1; the disease is urinary bladder cancer.